查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1713193

全球蟲媒病毒檢測市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032年）

Arbovirus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 180 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要調查結果

  • 蟲媒病毒檢測市場規模：10.944億美元（2025年）
  • 預計市場價值：15.211億美元（2032年）
  • 全球市場成長率：4.8%（2025-2032年的年複合成長率）

蟲媒病毒檢測市場：報告範圍

蟲媒病毒檢測在節肢動物傳播病毒感染疾病，包括登革熱、茲卡、基孔肯雅病毒、黃熱病和西尼羅河病毒。這些疾病主要透過蚊子和蜱蟲傳播，對公共衛生構成重大挑戰，尤其是在熱帶和亞熱帶地區。蟲媒病毒檢測市場包括用於醫院、診所、實驗室和現場監測計畫的分子診斷、血清學檢測和照護現場。蟲媒病毒感染疾病的流行，以及全球移民增加和氣候變遷對媒介生態系統的影響，推動對先進診斷解決方案的需求。

市場成長動力

由於都市化、全球旅行以及有利於蚊子繁殖的環境變化等因素，全球蟲媒病毒疾病的發生率激增，推動了全球蟲媒病毒檢測市場的發展。政府和非政府對感染疾病控制和公共衛生防範的資金增加刺激對疾病監測和診斷基礎設施的投資。 PCR和次世代定序等分子診斷技術的進步使得快速且準確地檢測蟲媒病毒成為可能，有助於早期療育和控制疫情。此外，流行地區對篩檢計劃的認知不斷提高和實施也支持了市場的成長。

市場限制

儘管前景光明，但該市場仍面臨挑戰，包括低收入地區診斷工具獲取管道有限、缺乏標準化檢測通訊協定以及訓練有素的實驗室負責人短缺。在一些國家，分子檢測成本高且保險覆蓋範圍有限，進一步限制了市場滲透。季節和趨勢導致的需求波動也會影響製造商的生產計畫和資源配置。此外，血清學檢測方法的交叉反應，尤其是與黃病毒的交叉反應，可能導致誤診，影響檢測可靠性和臨床決策。

市場機會

蟲媒病毒檢測市場透過可攜式照護現場診斷設備的創新提供了巨大的成長機會，這些設備可以快速提供結果並適合在疫情爆發期間現場使用。人工智慧和資料分析在流行病學建模中的整合將增強疾病預測和檢測部署策略。加強公私合營進行研發以及出現能夠同時檢測多種蟲媒病毒的多重檢測將簡化工作流程並降低診斷成本。擴大非旅行感染流行地區的檢測和建立全球疾病監測網路將進一步為市場擴張鋪平道路。

本報告研究了全球蟲媒病毒檢測市場，並對市場動態進行了詳細分析，包括成長動力、趨勢、機會和挑戰。

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 限制因素
    • 機會
    • 課題
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值考察

  • 監管格局
  • 測試類型採用分析
  • 技術進步
  • 疾病流行病學
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第4章 全球蟲媒病毒檢測市場展望

  • 主要亮點
    • 市場規模及與前一年同期比較
    • 絕對的商機
  • 市場規模分析與預測
    • 市場規模表現分析（2019-2024）
    • 當前市場規模分析與預測（2025-2032）
  • 全球蟲媒病毒檢測市場展望：檢測類型
    • 簡介/主要調查結果
    • 依檢測類型分類的市場規模績效分析（2019-2024）
    • 依檢測類型分類的當前市場規模分析和預測（2025-2032）
      • 血清學檢測
      • 分子診斷檢測
      • 其他
    • 市場吸引力分析：檢測類型
  • 全球蟲媒病毒檢測市場展望：病毒類型
    • 簡介/主要調查結果
    • 按病毒類型分類的市場規模表現分析（2019-2024年）
    • 目前市場規模分析及病毒類型預測（2025-2032）
      • 登革熱病毒
      • 茲卡病毒
      • 基孔肯雅病毒
      • 黃熱病毒
      • 西尼羅病毒
      • 日本腦炎病毒
      • 其他
    • 市場吸引力分析：病毒類型
  • 全球蟲媒病毒檢測市場展望：最終用戶
    • 簡介/主要調查結果
    • 依最終用戶分類的市場規模分析（2019-2024）
    • 目前市場規模分析及最終用戶預測（2025-2032）
      • 醫院和診所
      • 診斷實驗室
      • 研究中心
      • 公共衛生機構
      • 學術機構
    • 市場吸引力分析：最終用戶

第5章 全球蟲媒病毒檢測市場（依地區）展望

  • 主要亮點
  • 市場規模績效分析：依地區（2019-2024）
  • 目前市場規模分析及各地區預測（2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：地區

第6章 北美蟲媒病毒檢測市場展望

第7章 歐洲蟲媒病毒檢測市場展望

第8章 東亞蟲媒病毒檢測市場展望

第9章 南亞和大洋洲蟲媒病毒檢測市場展望

第10章 拉丁美洲蟲媒病毒檢測市場展望

第11章 中東與非洲蟲媒病毒檢測市場展望

第12章 競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：依市場
    • 競爭儀錶板
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Abbott Laboratories
    • Roche Diagnostics
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Siemens Healthineers AG
    • Danaher Corporation（includes Cepheid, Beckman Coulter）
    • QIAGEN NV
    • bioMerieux SA
    • Meridian Bioscience, Inc.
    • NovaTec Immundiagnostica GmbH
    • InBios International, Inc.
    • Artron Laboratories Inc.
    • SD Biosensor, Inc.
    • CTK Biotech, Inc.
    • Euroimmun AG（a PerkinElmer company）
    • 其他

第13章 附錄

簡介目錄
Product Code: PMRREP17032

Persistence Market Research has recently released a comprehensive report on the worldwide market for arbovirus testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global arbovirus testing market from 2025 to 2032.

Key Insights:

  • Arbovirus Testing Market Size (2025E): USD 1,094.4 Million
  • Projected Market Value (2032F): USD 1,521.1 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.8%

Arbovirus Testing Market - Report Scope:

Arbovirus testing plays a vital role in the diagnosis and surveillance of arthropod-borne viral infections such as dengue, Zika, chikungunya, yellow fever, and West Nile virus. These diseases are primarily transmitted by mosquitoes and ticks, posing significant public health challenges, particularly in tropical and subtropical regions. The arbovirus testing market comprises molecular diagnostics, serological tests, and point-of-care assays, used in hospitals, clinics, laboratories, and field surveillance programs. The increasing prevalence of arboviral outbreaks, coupled with rising global mobility and climate change effects on vector ecology, is driving demand for advanced diagnostic solutions.

Market Growth Drivers:

The global arbovirus testing market is propelled by the escalating incidence of arboviral diseases worldwide, driven by factors such as urbanization, global travel, and environmental changes that favor mosquito breeding. Rising government and non-governmental funding for infectious disease control and public health preparedness has spurred investments in disease surveillance and diagnostics infrastructure. Advancements in molecular diagnostic technologies, including PCR and next-generation sequencing, have enabled faster and more accurate detection of arboviruses, facilitating early intervention and outbreak containment. In addition, growing awareness and implementation of screening programs in endemic regions support market growth.

Market Restraints:

Despite the promising outlook, the market faces challenges including limited accessibility of diagnostic tools in low-income regions, lack of standardized testing protocols, and shortage of trained laboratory personnel. High costs associated with molecular tests and limited insurance coverage in some countries further restrict market penetration. Seasonal and outbreak-driven demand variability also affects production planning and resource allocation for manufacturers. Moreover, cross-reactivity in serological testing methods, particularly among flaviviruses, may lead to misdiagnosis, impacting test reliability and clinical decision-making.

Market Opportunities:

The arbovirus testing market presents substantial growth opportunities through innovations in portable, point-of-care diagnostic devices, which offer rapid results and are suitable for field use during outbreaks. Integration of artificial intelligence and data analytics in epidemiological modeling enhances disease forecasting and test deployment strategies. Increasing public-private partnerships for R&D and the emergence of multiplex assays capable of simultaneously detecting multiple arboviruses can streamline workflows and reduce diagnostic costs. Expansion of testing in non-endemic regions due to travel-related transmission and the establishment of global disease surveillance networks further open avenues for market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the arbovirus testing market globally?
  • Which testing technologies and platforms are gaining traction in endemic and non-endemic regions?
  • How are innovations in molecular diagnostics influencing the arbovirus testing landscape?
  • Who are the key players in the arbovirus testing market, and what strategies are they employing to remain competitive?
  • What are the emerging trends and future prospects in the global arbovirus testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global arbovirus testing market, including Abbott Laboratories, Thermo Fisher Scientific Inc., bioMerieux SA, and Bio-Rad Laboratories, Inc., are focusing on technology development, strategic collaborations, and geographical expansion to enhance their market presence. These companies are investing in advanced diagnostic platforms and launching rapid, multiplex, and high-throughput testing kits to address increasing demand for accurate and timely diagnostics. Partnerships with public health agencies and academic institutions support surveillance initiatives and product innovation. Continuous focus on regulatory approvals, training programs, and awareness campaigns is aiding in expanding market access, particularly in resource-limited settings.

Key Companies Profiled:

  • Abbott Laboratories
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Siemens Healthineers AG
  • Danaher Corporation (includes Cepheid, Beckman Coulter)
  • QIAGEN N.V.
  • bioMerieux SA
  • Meridian Bioscience, Inc.
  • NovaTec Immundiagnostica GmbH
  • InBios International, Inc.
  • Artron Laboratories Inc.
  • SD Biosensor, Inc.
  • CTK Biotech, Inc.
  • Euroimmun AG (a PerkinElmer company)
  • Others

Market Segmentation

By Test Type

  • Serological Tests
  • Molecular Diagnostic Tests
  • Others

By Virus Type

  • Dengue Virus
  • Zika Virus
  • Chikungunya Virus
  • Yellow Fever Virus
  • West Nile Virus
  • Japanese Encephalitis Virus
  • Others

By End-user

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Centers
  • Public Health Agencies
  • Academic Institutions

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Test Type Adoption Analysis
  • 3.3. Technological Advancements
  • 3.4. Disease Epidemiology
  • 3.5. Value Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global Arbovirus Testing Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Arbovirus Testing Market Outlook: Test Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
    • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
      • 4.3.3.1. Serological Tests
      • 4.3.3.2. Molecular Diagnostic Tests
      • 4.3.3.3. Others
    • 4.3.4. Market Attractiveness Analysis: Test Type
  • 4.4. Global Arbovirus Testing Market Outlook: Virus Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Virus Type, 2019-2024
    • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
      • 4.4.3.1. Dengue Virus
      • 4.4.3.2. Zika Virus
      • 4.4.3.3. Chikungunya Virus
      • 4.4.3.4. Yellow Fever Virus
      • 4.4.3.5. West Nile Virus
      • 4.4.3.6. Japanese Encephalitis Virus
      • 4.4.3.7. Others
    • 4.4.4. Market Attractiveness Analysis: Virus Type
  • 4.5. Global Arbovirus Testing Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals & Clinics
      • 4.5.3.2. Diagnostic Laboratories
      • 4.5.3.3. Research Centers
      • 4.5.3.4. Public Health Agencies
      • 4.5.3.5. Academic Institutions
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Arbovirus Testing Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Arbovirus Testing Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Test Type
    • 6.2.3. By Virus Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 6.4.1. Serological Tests
    • 6.4.2. Molecular Diagnostic Tests
    • 6.4.3. Others
  • 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 6.5.1. Dengue Virus
    • 6.5.2. Zika Virus
    • 6.5.3. Chikungunya Virus
    • 6.5.4. Yellow Fever Virus
    • 6.5.5. West Nile Virus
    • 6.5.6. Japanese Encephalitis Virus
    • 6.5.7. Others
  • 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals & Clinics
    • 6.6.2. Diagnostic Laboratories
    • 6.6.3. Research Centers
    • 6.6.4. Public Health Agencies
    • 6.6.5. Academic Institutions
  • 6.7. Market Attractiveness Analysis

7. Europe Arbovirus Testing Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Test Type
    • 7.2.3. By Virus Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 7.4.1. Serological Tests
    • 7.4.2. Molecular Diagnostic Tests
    • 7.4.3. Others
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 7.5.1. Dengue Virus
    • 7.5.2. Zika Virus
    • 7.5.3. Chikungunya Virus
    • 7.5.4. Yellow Fever Virus
    • 7.5.5. West Nile Virus
    • 7.5.6. Japanese Encephalitis Virus
    • 7.5.7. Others
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals & Clinics
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Research Centers
    • 7.6.4. Public Health Agencies
    • 7.6.5. Academic Institutions
  • 7.7. Market Attractiveness Analysis

8. East Asia Arbovirus Testing Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Test Type
    • 8.2.3. By Virus Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 8.4.1. Serological Tests
    • 8.4.2. Molecular Diagnostic Tests
    • 8.4.3. Others
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 8.5.1. Dengue Virus
    • 8.5.2. Zika Virus
    • 8.5.3. Chikungunya Virus
    • 8.5.4. Yellow Fever Virus
    • 8.5.5. West Nile Virus
    • 8.5.6. Japanese Encephalitis Virus
    • 8.5.7. Others
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals & Clinics
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Research Centers
    • 8.6.4. Public Health Agencies
    • 8.6.5. Academic Institutions
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Arbovirus Testing Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Test Type
    • 9.2.3. By Virus Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 9.4.1. Serological Tests
    • 9.4.2. Molecular Diagnostic Tests
    • 9.4.3. Others
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 9.5.1. Dengue Virus
    • 9.5.2. Zika Virus
    • 9.5.3. Chikungunya Virus
    • 9.5.4. Yellow Fever Virus
    • 9.5.5. West Nile Virus
    • 9.5.6. Japanese Encephalitis Virus
    • 9.5.7. Others
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals & Clinics
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Research Centers
    • 9.6.4. Public Health Agencies
    • 9.6.5. Academic Institutions
  • 9.7. Market Attractiveness Analysis

10. Latin America Arbovirus Testing Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Test Type
    • 10.2.3. By Virus Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 10.4.1. Serological Tests
    • 10.4.2. Molecular Diagnostic Tests
    • 10.4.3. Others
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 10.5.1. Dengue Virus
    • 10.5.2. Zika Virus
    • 10.5.3. Chikungunya Virus
    • 10.5.4. Yellow Fever Virus
    • 10.5.5. West Nile Virus
    • 10.5.6. Japanese Encephalitis Virus
    • 10.5.7. Others
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals & Clinics
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Research Centers
    • 10.6.4. Public Health Agencies
    • 10.6.5. Academic Institutions
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Arbovirus Testing Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Test Type
    • 11.2.3. By Virus Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 11.4.1. Serological Tests
    • 11.4.2. Molecular Diagnostic Tests
    • 11.4.3. Others
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 11.5.1. Dengue Virus
    • 11.5.2. Zika Virus
    • 11.5.3. Chikungunya Virus
    • 11.5.4. Yellow Fever Virus
    • 11.5.5. West Nile Virus
    • 11.5.6. Japanese Encephalitis Virus
    • 11.5.7. Others
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals & Clinics
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Research Centers
    • 11.6.4. Public Health Agencies
    • 11.6.5. Academic Institutions
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott Laboratories
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Test Types
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Roche Diagnostics
    • 12.3.3. Thermo Fisher Scientific Inc.
    • 12.3.4. Bio-Rad Laboratories, Inc.
    • 12.3.5. Siemens Healthineers AG
    • 12.3.6. Danaher Corporation (includes Cepheid, Beckman Coulter)
    • 12.3.7. QIAGEN N.V.
    • 12.3.8. bioMerieux SA
    • 12.3.9. Meridian Bioscience, Inc.
    • 12.3.10. NovaTec Immundiagnostica GmbH
    • 12.3.11. InBios International, Inc.
    • 12.3.12. Artron Laboratories Inc.
    • 12.3.13. SD Biosensor, Inc.
    • 12.3.14. CTK Biotech, Inc.
    • 12.3.15. Euroimmun AG (a PerkinElmer company)
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations